-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Aytu Biopharma, Inc annual/quarterly Depreciation, Depletion and Amortization history and growth rate from 2012 to 2024.
- Aytu Biopharma, Inc Depreciation, Depletion and Amortization for the quarter ending September 30, 2023 was $2.23M, a 3.09% decline year-over-year.
- Aytu Biopharma, Inc annual Depreciation, Depletion and Amortization for 2024 was $8.27M, a 6.16% decline from 2023.
- Aytu Biopharma, Inc annual Depreciation, Depletion and Amortization for 2023 was $8.82M, a 13.1% decline from 2022.
- Aytu Biopharma, Inc annual Depreciation, Depletion and Amortization for 2022 was $10.1M, a 10.3% increase from 2021.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)